# Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma

> **NCT04495894** · PHASE2 · TERMINATED · sponsor: **Emory University** · enrollment: 68 (actual)

## Conditions studied

- Non-small Cell Lung Cancer
- Renal Cell Carcinoma

## Interventions

- **DRUG:** Preoperative Ketorolac

## Key facts

- **NCT ID:** NCT04495894
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-24
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-02-01
- **Target enrollment:** 68 (ACTUAL)
- **Why stopped:** This study was terminated after interim analyses showed no benefits.
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04495894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04495894, "Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT04495894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*